⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IPSC News
Century Therapeutics, Inc. Common Stock
Form 8-K
sec.gov
IPSC
Form 8-K
sec.gov
IPSC
New CNTY-813 Preclinical Data Demonstrate Durable Glucose Control, Immune Evasion Under Alloimmune Pressure, and Scalable Manufacturing at ADA 2026
globenewswire.com
IPSC
A Third Cancer Drug Just Entered the Clinic at an Under-$20-Million Company
prnewswire.com
GTBP
IPHA
INKT
IPSC
Form 8-K
sec.gov
CRBP
IPSC
Corbus Pharmaceuticals Appoints Pharma Industry Veteran Brent Pfeiffenberger to Board of Directors
globenewswire.com
IPSC
CRBP
Form 8-K
sec.gov
IPSC
Century Therapeutics Reports First Quarter Financial Results and Business Updates
globenewswire.com
IPSC
Century Therapeutics Selected for Oral Presentation of CNTY‑813 Preclinical Data at the American Diabetes Association 86th Scientific Sessions
globenewswire.com
IPSC
Methyl Methacrylate Adhesives Market worth $2.46 billion by 2030 - Exclusive Report by MarketsandMarkets™
prnewswire.com
MMM
ITW
IPSC
HUN
PH